{"id":"W2913106255","doi":"10.1016/j.jaci.2018.11.053","title":"GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis","year":2019,"lang":"en","type":"article","venue":"Journal of Allergy and Clinical Immunology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":222,"is_retracted":false,"has_abstract":true,"ca_institutions":"Innovaderm (Canada)","funders":"Glenmark Pharmaceuticals","keywords":"Eczema Area and Severity Index; Atopic dermatitis; Medicine; Placebo; CCL11; Adverse effect; CCL17; Internal medicine; Body surface area; Gastroenterology; Skin biopsy; Biopsy; Immunology; CXCL10; Chemokine; Inflammation; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005645875,0.000440151,0.001167852,0.0002294581,0.0001641399,0.0002627198,0.0001718771,0.0002318325,0.0009337839],"category_scores_gemma":[0.0002760292,0.0001389266,0.000310503,0.0002211025,0.0002101566,0.0001919028,0.0001203304,0.0006231373,0.0002069441],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002405759,"about_ca_system_score_gemma":0.0002629418,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004531397,"about_ca_topic_score_gemma":0.001018006,"domain_scores_codex":[0.9998672,0.00004617449,0.000009553776,0.0000219812,0.00002752546,0.00002756311],"domain_scores_gemma":[0.9998355,0.00003627779,0.00004881911,0.000008710266,0.00001463141,0.0000559239],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1719133,0.01941274,0.1124125,0.001280483,0.0007847081,0.0007017,0.0002751812,0.001972585,0.3994487,0.0001284168,0.00323393,0.2884357],"study_design_scores_gemma":[0.04269564,0.2616691,0.6580925,0.0001139041,0.0009693505,0.002423049,0.0001905852,0.002617247,0.02727329,0.0001836098,0.003727894,0.00004384321],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997107,0.0020258,0.00009819851,0.00006401158,0.00001307512,0.00008443504,0.0001065465,0.00002972169,0.0004711982],"genre_scores_gemma":[0.9980639,0.000887188,0.0003343466,0.000164502,0.00002631568,0.00005287756,0.0001452422,0.000004191554,0.0003214782],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001167852,"threshold_uncertainty_score":0.003123879,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01003439173240979,"score_gpt":0.2991725719075664,"score_spread":0.2891381801751566,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}